Post by
antigua1987 on Mar 09, 2021 9:04am
March21 corp pres-
barely 3 changes fr Jan21: 1)monol OV- median duration of response now>12months, 2)dropped institutional invstr page, 3)WellsFargo analyst out.
Comment by
alexmed95 on Mar 09, 2021 9:25am
Won't lie, not so much good news for a long time...
Comment by
Breakthorough on Mar 09, 2021 9:31am
The important thing is that the three announcements dued to Q1 (DLBCL Trial design, ovarian biomarker, B. Trial interim data) are still announced for Q1 (see p. 28), meaning: during the three weeks that we have ahead us.